Cite
HARVARD Citation
Arai, T. et al. (2018). Efficacy and safety of ombitasvir/paritaprevir/ritonavir combination therapy for genotype 1b chronic hepatitis C patients complicated with chronic kidney disease. Hepatology research. 48 (7), pp. 549-555. [Online].